The latest discoveries in Endocrinology
A concise briefing on the most relevant research developments in your field, curated for clarity and impact.
A negative trial offers clarity on PCOS and pregnancy supplements
A recent double-blind, placebo-controlled trial investigating the use of myo-inositol supplementation in pregnant individuals with polycystic ovary syndrome (PCOS) found no significant benefit in preventing pregnancy complications. This neutral finding contrasts with earlier, smaller studies that suggested a potential advantage. The result provides clinical reassurance that routine supplementation may not be necessary, helping to avoid unnecessary interventions and costs for patients.
Why it might matter to you:
This high-quality evidence directly informs clinical guidance for managing PCOS in pregnancy, a core aspect of gynecological endocrinology. It helps refine practice by identifying an intervention that may not warrant routine recommendation, allowing for a more streamlined and cost-effective approach to prenatal care. This supports a shift towards evidence-based stewardship of supplements in this patient population.
If you wish to receive daily, weekly, biweekly or monthly personalized briefings like this, please.
Stay curious. Stay informed — with
Science Briefing.
You can update your preferences at
My Preferences.
